Epilepsy care in Ontario: An economic analysis of increasing access to epilepsy surgery

Ontario Health Technology Assessment Series

Volumn 12, Issue 18, 2012, Pages

  Bowen, James M ^a,b   Snead, O Carter ^c,d   Chandra, Kiran ^a,b   Blackhouse, Gord ^a,b   Goeree, Ron ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BUDGET; CANADA; CHILD; CHILD HEALTH CARE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; ELECTROENCEPHALOGRAPHY; FEMALE; GENERAL SURGERY; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HOSPITAL BED CAPACITY; HUMAN; INCIDENCE; INFANT; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MIDDLE AGED; NEUROSURGERY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; PEDIATRIC HOSPITAL; PEDIATRIC SURGERY; PRESCHOOL CHILD; PREVALENCE; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; RETROSPECTIVE STUDY; RURAL HEALTH CARE; SCHOOL CHILD; TREATMENT RESPONSE; YOUNG ADULT; COST BENEFIT ANALYSIS; ECONOMICS; EPILEPSY; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; TREATMENT OUTCOME;

ADULT; CHILD; COST-BENEFIT ANALYSIS; EPILEPSY; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; NEUROSURGICAL PROCEDURES; ONTARIO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PREVALENCE; QUALITY-ADJUSTED LIFE YEARS;

EID: 85042036354     PISSN: 19157398     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tellez-Zenteno JF, Pondal-Sordo M, Matijevic S, Wiebe S. National and regional prevalence of self-reported epilepsy in Canada. Epilepsia. 2004 Dec;45(12):1623-9.
2. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000 Feb 3;342(5):314-9.
3. Ontario Health Technology Advisory Committee (OHTAC). Appendix 1. Epilepsy surgery in Ontario: increasing access and standardizing care (March 2011). In: OHTAC recommendation: care for drug-refractory epilepsy in Ontario. Toronto: Ontario Health Technology Advisory Committee (OHTAC); 2012. [cited 15-May-2012]. Available from: http://www.hqontario.ca/en/mas/ohtac_rec_openComment.html
4. Cross JH, Jayakar P, Nordli D, Delalande O, Duchowny M, Wieser HG et al. Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia. 2006 Jun;47(6):952-9.
5. Ontario Health Technology Advisory Committee (OHTAC). Appendix 2. Report of the OHTAC Expert Panel on a Provincial Strategy for Epilepsy Care in Ontario (August 2011). In: OHTAC recommendation: care for drug-refractory epilepsy in Ontario. Toronto: Ontario Health Technology Advisory Committee (OHTAC); 2012. [cited 15-May-2012]. Available from: http://www.hqontario.ca/en/mas/ohtac_rec_openComment.html
6. Labiner DM, Bagic AI, Herman ST, Fountain NB, Walczak TS, Gumnit RJ. Essential services, personnel, and facilities in specialized epilepsy centers--revised 2010 guidelines. Epilepsia. 2010 Nov;51(11):2322-33.
7. Langfitt J, Wiebe S. Cost-effectiveness of epilepsy therapy: How should treatment effects be measured? Epilepsia. 2002;43(Suppl 4):17-24.
8. Wiebe S, Gafni A, Blume WT, Girvin JP. The economics of surgery for temporal lobe epilepsy. J Epilepsy. 1996;9(2):144-5.
9. King JT, Jr., Sperling MR, Justice AC, O'Connor MJ. A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy. J Neurosurg. 1997;87(1):20-8.
10. Bowen JM, Snead OC, Hopkins RB, Elliott I, Burke N, Atkin J et al. Diagnostic evaluation of infants, children and adolescents with epilepsy for surgery candidacy and the role of magnetoencephalography (MEG). Hamilton (ON): Programs for Assessment of Technology in Health, St. Joseph's Healthcare Hamilton/McMaster University; 2011 [cited 9-May-2012]. Available from: http://www.path-hta.ca/Libraries/Reports/MEG_OHTAC_report.sflb.ashx.
11. Wiebe S, Bellhouse DR, Fallahay C, Eliasziw M. Burden of epilepsy: the Ontario Health Survey. Can J Neurol Sci. 1999 Nov;26(4):263-70.
12. Statistics Canada. Estimates of population, by age group and sex for July 1, Canada, provinces and territories annual (persons unless otherwise noted) - Table 051-0001. Ottawa: Government of Canada; 2011 [cited 15-Feb-2012]. Available from: http://www5.statcan.gc.ca/cansim/a26?lang=eng&retrLang=eng&id=0510001&tabMode=dataTable&srchLan=-1&p1=-1&p2=9.
13. Kotsopoulos IA, van MT, Kessels FG, de Krom MC, Knottnerus JA. Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia. 2002 Nov;43(11):1402-9.
14. Statistics Canada. Estimates of population (2006 Census and administrative data), by age group and sex, Canada, provinces, territories, health regions (2011 boundaries) and peer groups annual (number) - Table 109-5325. Ottawa: Government of Canada; 2011 [cited 15-Feb-2012]. Available from: http://www5.statcan.gc.ca/cansim/a26?lang=eng&retrLang=eng&id=1095325&tabMode=dataTa ble&srchLan=-1&p1=-1&p2=9.
15. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311-8.
16. Widjaja E, Li B, Schinkel CD, Ritchie LP, Weaver J, Snead OC et al. Cost-effectiveness of pediatric epilepsy surgery compared to medical treatment in children with intractable epilepsy. Epilepsy Res. 2011;94(1-2):61-8.
17. Jette N, Quan H, Faris P, Dean S, Li B, Fong A et al. Health resource use in epilepsy: significant disparities by age, gender, and aboriginal status. Epilepsia. 2008 Apr;49(4):586-93.
18. Ontario Case Costing Initiative. OCCI Case Analysis Tool. Toronto: Ontario Case Costing Initiative; 2012 [cited 15-Feb-2012]. Available from: http://www.occp.com/mainPage.htm.
19. Tanriverdi T, Poulin N, Olivier A. Life 12 years after temporal lobe epilepsy surgery: a longterm, prospective clinical study. Seizure. 2008 Jun;17(4):339-49.
20. Selai C, Kaiser S, Trimble M, Price M. Evaluation of the relationship between epilepsy severity and utility. 5[6]. 2002 512-513 p.
21. Hawkins N, Epstein D, Drummond M, Wilby J, Kainth A, Chadwick D et al. Assessing the costeffectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model. Med Decis Making. 2005 Sep;25(5):493-510.
22. Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C et al. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv.
23. Statistics Canada. Life Tables, Canada, Provinces and Territories, 2000-2002. Table 2b Complete life table, Canada, 2000 to 2002: females. Ottawa: Statistics Canada; 2006 [cited 14-May-2012]. Available from: http://www.statcan.gc.ca/pub/84-537-x/t/pdf/4198611-eng.pdf.
24. Statistics Canada. Life Tables, Canada, Provinces and Territories, 2000-2002. Table 2b Complete life table, Canada, 2000 to 2002: males. Ottawa: Statistics Canada; 2006 [cited 14-May-2012]. Available from: http://www.statcan.gc.ca/pub/84-537-x/t/pdf/4198612-eng.pdf.
25. Messori A, Trippoli S, Becagli P, Cincotta M, Labbate MG, Zaccara G. Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysis. Eur J Clin Pharmacol. 1998 Feb;53(6):421-7.
26. Wiebe S, Jette N. Epilepsy surgery utilization: who, when, where, and why? Curr Opin Neurol. 2012 Apr;25(2):187-93.
27. Fountain NB, Van Ness PC, Swain-Eng R, Tonn S, Bever CT, Jr. Quality improvement in neurology: AAN epilepsy quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 2011 Jan 4;76(1):94-9.